| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |